Rodney Rocconi, MD
Gynecologic Oncology · Jackson, MSNPI 1730131210
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $157,624 of the $223,870 with a category attached, or 70.4%. 22 manufacturers reported payments, led by GSK at 53.3% of the total. Reporting peaked in 2022 at $84,102 and has fallen 98.1% since, to $1,589 in 2025.
Across 191 payments — averaging $1172.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$119K
- Eisai Inc.$40K
- Genentech USA, Inc.$21K
- Clovis Oncology, Inc.$19K
- Roche Diagnostics Corporation$8K
- Immunogen, Inc.$7K
- plus $9K from 16 others
Across 113 payments — averaging $11,718 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merck$926K
- Tesaro, Inc.$202K
- AbbVie$105K
- Exelixis Inc.$43K
- AstraZeneca$25K
- GSK$16K
- plus $7K from 1 others
What the payments were for
- Consulting fees$36,75316%
- Speaking & faculty fees$157,62470%
- Travel & lodging$23,76911%
- Food & beverage$5,7253%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 77 | $119,274 |
| Eisai Inc. | 36 | $40,033 |
| Genentech USA, Inc. | 12 | $21,484 |
| Clovis Oncology, Inc. | 16 | $18,999 |
| Roche Diagnostics Corporation | 2 | $8,180 |
| Immunogen, Inc. | 8 | $6,724 |
| Intuitive Surgical | 9 | $4,168 |
| AbbVie | 4 | $2,338 |
| Histosonics, Inc. | 2 | $1,285 |
| Baxter Healthcare | 3 | $261 |
| Seagen Inc. | 1 | $154 |
| Medical Device Business Services, Inc. | 1 | $149 |
| Dilon Technologies, Inc. | 1 | $142 |
| Biom'up SA | 1 | $116 |
| Merck | 5 | $111 |
| AstraZeneca(2 entities) | 5 | $100 |
| Caris MPI, Inc. | 1 | $95 |
| Johnson & Johnson(2 entities) | 3 | $95 |
| Genmab U.S., Inc. | 1 | $92 |
| Regeneron Healthcare Solutions, Inc. | 1 | $25 |
| Genentech, Inc. | 1 | $24 |
| Novartis | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ZEJULA$110,357
- LENVIMA$39,422
- Avastin$21,484
- Rubraca$18,882
- Elahere$8,873
- JEMPERLI$8,230
- BENCHMARK SPECIAL STAINS WASH II$8,180
- Da Vinci Surgical System$3,927
- Harmonic$149
- HemoBlast Bellows$142
- PerClot$124
- HEMOBLAST$116
How this compares
Too few gynecologic oncology providers in Mississippito place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gynecologic oncology in Jackson
- Mildred RidgwayJackson$37K
- Christen Walters HaygoodJackson$27K
- Donald SeagoJackson$8K
- James MooreJackson$4K
- Michael FinanPascagoula$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.